Yun Feng Li
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Yun Feng Li currently works at Mabpharm Ltd., as Co-Secretary & Executive Director from 2024, Taizhou Mabtech Pharmaceutical Co. Ltd., as Director & Deputy General Manager from 2018, Shanghai Shengheng Biotechnology Ltd., as Director from 2019, and Taizhou Mabtech Biotechnology Ltd., as Deputy General Manager from 2016.
Mr. Li also formerly worked at Shanghai Biomabs Pharmaceuticals Co., Ltd., as Deputy General Manager from 2016 to 2018, Shanghai Xingsheng Pharmaceutical Co., Ltd., as General Manager from 2012 to 2016, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., as Deputy General Manager from 2002 to 2009, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., as Deputy General Manager from 2010 to 2012, Shanghai Zhangjiang Biotechnology Co. Ltd., as Deputy General Manager from 2016 to 2017, Shanghai Sinomab Biotechnology Co. Ltd., as Deputy General Manager from 2016 to 2018, and Shanghai National Engineering Research Center of Antibody Medi, as Deputy General Manager from 2009 to 2010.
Mr. Li received his undergraduate degree in 1998 from Nanjing Normal University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MABPHARM LIMITED -.--% | 30.06.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MABPHARM LIMITED | Direktor/Vorstandsmitglied | 20.07.2018 |
Taizhou Mabtech Biotechnology Ltd. | Corporate Officer/Principal | 01.03.2016 |
Taizhou Mabtech Pharmaceutical Co. Ltd. | Direktor/Vorstandsmitglied | 01.08.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
Shanghai Sinomab Biotechnology Co. Ltd. | Corporate Officer/Principal | 01.08.2018 |
Shanghai Biomabs Pharmaceuticals Co., Ltd. | Corporate Officer/Principal | 01.08.2018 |
Shanghai Zhangjiang Biotechnology Co. Ltd. | Corporate Officer/Principal | 01.07.2017 |
Shanghai Xingsheng Pharmaceutical Co., Ltd.
Shanghai Xingsheng Pharmaceutical Co., Ltd. Financial ConglomeratesFinance Invests and transfers technologies | Corporate Officer/Principal | 01.03.2016 |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Corporate Officer/Principal | 01.11.2012 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Nanjing Normal University
Nanjing Normal University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Biomabs Pharmaceuticals Co., Ltd. | |
Shanghai Xingsheng Pharmaceutical Co., Ltd.
Shanghai Xingsheng Pharmaceutical Co., Ltd. Financial ConglomeratesFinance Invests and transfers technologies | Finance |
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Mabpharm Ltd.
Mabpharm Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company develops pipeline contains to treat cancer and autoimmune diseases | Commercial Services |
Taizhou Mabtech Pharmaceutical Co. Ltd. | |
Taizhou Mabtech Biotechnology Ltd. | |
Shanghai Zhangjiang Biotechnology Co. Ltd. | |
Shanghai Sinomab Biotechnology Co. Ltd. | |
Shanghai National Engineering Research Center of Antibody Medi |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen